drugset / Trial / NCT02753114

Prehospital Analgesia With Intra-Nasal Ketamine

NCT02753114 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Acute painful conditions make-up a large proportion of pre-hospital transports in British Columbia (BC) yet Basic Life Support (BLS) paramedics have limited options to provide analgesia and therefore adequate and timely pain relief is often significantly delayed. Inhaled nitrous oxide is commonly used as a pre-hospital analgesic and is considered "usual care" for pre-hospital providers in BC, but its utility in severe pain is uncertain. Moreover, nitrous oxide is limited in its effectiveness by a short duration of action, nausea, vomiting, and the necessity for patient cooperation. IN Ketamine has been shown to provide rapid, easily-administered, and well-tolerated analgesia in many settings. The investigators believe that the addition of IN ketamine to usual care with nitrous oxide inhalation for adults experiencing moderate to severe intensity acute pain in the pre-hospital setting will result in improved pain severity, improved patient-reported comfort, and improved patient satisfaction.

Timeline

Start
2017-11-06
Primary completion
2018-05-24
Completion
2018-05-24

Outcome

Met primary endpoint

paper Seventy-six percent of intranasal ketamine patients versus 41% of placebo patients reported a greater than or equal to 2-point VNRS reduction at 30 minutes. PMID 30926189 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 30 mg Intranasal
Subject Ketamine Small molecule 50 mg Intranasal
Subject Ketamine Small molecule 75 mg Intranasal

Indications

No indication recorded.